Abstract
Group B streptococcal (GBS) is a Gram-positive bacterium that is commonly found in the gastrointestinal tract and urogenital tract. GBS infestation during pregnancy is a significant contributor to maternal and neonatal morbidity and mortality globally. This article aims to discuss the infectious diseases caused by GBS in the field of obstetrics and gynecology, as well as the challenges associated with the detection, treatment, and prevention of GBS.
Reference241 articles.
1. Safety and immunogenicity of a novel hexavalent group B streptococcus conjugate vaccine in healthy, non-pregnant adults: a phase 1/2, randomised, placebo-controlled, observer-blinded, dose-escalation trial;Absalon;Lancet Infect. Dis.,2021
2. Advances towards licensure of a maternal vaccine for the prevention of invasive group B streptococcus disease in infants: a discussion of different approaches;Absalon;Hum. vaccines Immunother.,2022
3. Immunogenicity and protective efficacy of a prototype pneumococcal bioconjugate vaccine;Aceil;Vaccine,2022
4. Risk-based maternal group B Streptococcus screening strategy is compatible with the implementation of neonatal early-onset sepsis calculator;Achten;Clin. Exp. Pediatr.,2020
5. ACOG committee opinion. Prevention of early-onset group B streptococcal disease in newborns. Number 173--June 1996. Committee on Obstetric Practice. American College of Obstetrics and Gynecologists;Int. J. Gynaecol. obstetrics official organ Int. Fed. Gynaecol. Obstetrics,1996